Testing two new high blood pressure medicines together
Part of Heart & circulation clinical trials.
This trial tests a combination of two new medications (AD-227A and AD-227B) to see if they work better together for people with essential (common) high blood pressure. It could be a new treatment option to help control your blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with high blood pressure (essential hypertension).
- You are willing to take two study medications together.
- You do not have high blood pressure caused by another condition (secondary hypertension).
- You are able to give your informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
This study tests a new combination blood pressure medicine (HCP1803-4) for people with essential hypertension. It aims to see if the medicine works better than current options and is safe for long-term use.
This trial studies how two experimental drugs (AD-2321 and AD-2322) interact in the body and if they are safe for healthy volunteers. It is a Phase 1 study open to healthy adults.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.